STAT+: Structure Therapeutics reports significant weight loss from mid-stage GLP-1 pill
STAT [Unofficial]
March 16, 2026
An experimental obesity pill from Structure Therapeutics helped patients lose significant weight in a mid-stage trial, with a Phase 3 study in the works.
Discussion in the ATmosphere